Vincerx Pharma Inc expected to post a loss of 93  cents a share - Earnings Preview

Vincerx Pharma

13/05/2022 14:57

* Vincerx Pharma Inc  VINC.OQ   VINC.O  is expected
to report
results on August 10 (estimated).
    * ​Refinitiv's mean analyst estimate for Vincerx Pharma Inc
is for
a loss of 93 cents per share. For the same quarter last year,
the company reported a loss of 12 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had risen by
about 16.5%
in the last three months. ​
    * Wall Street's median 12-month price target for Vincerx
Pharma
Inc is $20.5​, above​ its last closing price of $2.29. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2022  -0.72       -0.76                        
 Dec. 31 2022  -0.87       -0.93      -0.31     Beat    66.7
 Sep. 30 2021  -0.86       -0.85      -1.39     Missed  -63.9​
 Jun. 30 2021              -0.37      -0.12     Beat    68
 ​​Mar.        -0.32       -0.32      -0.46     Missed  -43.7
 31 2021                                                
                                                        ​
 This summary was machine generated May 13 at 13:57 GMT.  All
figures in US dollars  unless otherwise stated